Elevated TGF-β signaling was also identified in the transcriptomic profile of 176 ccRCC patients, correlated with poor disease survival and tumor metastasis (Zhao et al., 2006; Sjölund et al., 2011). The gene discussed is TGFB1; the disease is nonpapillary renal cell carcinoma.